Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.55 |
| ▸ | CRBN | Q96SW2 | 15/20 | 0.53 |
| ▸ | DDB1 | Q16531 | 10/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.49 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.48 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23729263 | 0.95 | IRAK4 (0.52) | IRAK4CRBNDDB1ALDH1A1CHRM2 | |
| SCHEMBL23705491 | 0.86 | CRBN (0.59) | IRAK4CRBNDDB1ALDH1A1CHRM2 | |
| SCHEMBL30058706 | 0.86 | CRBN (0.59) | IRAK4CRBNDDB1ALDH1A1CHRM2 | |
| SCHEMBL23705600 | 0.85 | CRBN (0.56) | IRAK4CRBNDDB1ALDH1A1CHRM2 | |
| SCHEMBL22291300 | 0.85 | CRBN (0.58) | IRAK4CRBNDDB1ALDH1A1CHRM2 | |
| SCHEMBL23705611 | 0.83 | CRBN (0.55) | IRAK4CRBNDDB1ALDH1A1CHRM2 | |
| SCHEMBL23705755 | 0.82 | LTA4H (0.55) | IRAK4CRBNDDB1ALDH1A1CHRM2 | |
| SCHEMBL29617053 | 0.82 | LTA4H (0.55) | IRAK4CRBNDDB1ALDH1A1CHRM2 | |
| SCHEMBL23705552 | 0.82 | CRBN (0.54) | IRAK4CRBNDDB1ALDH1A1CHRM2 | |
| SCHEMBL23729483 | 0.82 | CRBN (0.54) | IRAK4CRBNDDB1ALDH1A1CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022109396-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. (US) | 2022-05-27 | — | — | WO | disclosed |
| WO-2021155321-A2 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. (US) | 2021-08-05 | — | — | WO | disclosed |